Cotinga Pharmaceuticals Inc. buy krebskrebs
Start price
28.04.20
/
50%
€0.019
Target price
04.11.21
€0.010
Performance (%)
-56.76%
End price
05.11.21
-
Summary
This prediction is currently being closed. Massive losses of -56.76% have been the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Cotinga Pharmaceuticals Inc. | - | - | - | - |
iShares Core DAX® | -3.033% | -0.013% | 11.953% | 15.609% |
iShares Nasdaq 100 | -3.554% | -2.546% | 30.128% | 44.540% |
iShares Nikkei 225® | -3.938% | 2.183% | 11.741% | 8.345% |
iShares S&P 500 | -1.517% | -0.882% | 25.752% | 42.388% |
Comments by krebskrebs for this prediction
In the thread Cotinga Pharmaceuticals Inc. diskutieren
Buy mit Kursziel 0,01
In the thread Trading Cotinga Pharmaceuticals Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten